News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
New drug targets systems protecting cancer from DNA damage
A new drug that blocks the ability of tumours to repair their DNA has shown positive results in a phase I trial including patients with ovarian, breast, prostate and lung cancer.
Kinase inhibitors: the science behind a revolution
A little more than a decade ago, the prospects for people with chronic myelogenous leukaemia (CML) were rather bleak. Common treatments included high-risk bone marrow transplants, which required at least four weeks in hospital and often led to severe complications down the line.
High-tech scan could help women avoid radical cervical cancer surgery
New high-resolution MRI scan technology gives doctors and patients the detailed information they need to plan precisely targeted surgery.
Scientists uncover ‘switch-flipping’ stem cell mechanism that could lead to new breast cancer therapies
The discovery of a pathway that helps stem cells grow into different types of breast tissue could lead to new treatments for aggressive breast cancer.
Double-pronged attack overcomes bladder cancer’s drug resistance
Combining two different targeted therapies could greatly increase the effectiveness of bladder cancer treatments by blocking a tumour’s path to drug resistance, a new study reports.
Pioneers receive honorary ICR degrees
Postgraduate degrees have been awarded to over 80 students, while honours were received by Professor Dame Janet Husband, Professor Sir Mike Stratton and The Honourable Thomas Henderson for their contributions to cancer research.
‘Homing’ radioactive injection shows benefit in prostate cancer trial
A new treatment for advanced prostate cancer that homes in on tumours has shown significant patient benefit in clinical trials, say ICR researchers.
Using cancer epidemiology to understand the causes of the disease
The roots of the modern-day study of cancer risk lie all the way back in the nineteenth century at a nunnery in Italy. It was here in 1842 that a doctor called Rigoni-Stern noticed that nuns virtually never suffered from cervical cancer but had a higher than usual incidence of breast cancer, and wondered whether the explanation might lie in the nuns’ celibacy.
New report pushes for stratified medicine
Read the ICR response to the Academy of Medical Sciences report, which makes recommendations to remove barriers to the development and adoption of stratified medicine.
Measles virus improves radiotherapy treatment
A new combined treatment using the measles virus to target cancer could greatly improve bowel and head & neck cancer treatment, say ICR researchers
New tumour tracker could target moving lung tumours as patients breathe
A new, targeted approach to radiotherapy could improve treatment of lung cancer by tracking a tumour’s movements as patients breathe in and out.
Scientists identify new genetic driver for breast cancer
An over-active gene called GNAS may help drive the growth of some types of difficult-to-treat breast cancers, ICR scientists have found.
